RALEIGH, North Carolina, January 18 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that its Director of Clinical Operations for PRA India, Pramod Kabra, M.D. will host an audio conference to discuss the advantages of conducting clinical trials in India and the reasons why the region is irresistible for global clinical development. Dr. Kabra will present the audio conference on 28 January 2010 from 11:30 a.m. to 12:30 p.m. EST. For additional information and to register, please navigate to www.praintl.com and click on Events under the News and Events heading.
Dr. Kabra's discussion will focus on the major factors that have made India one of the most attractive regions in the world to conduct clinical trial research: large patient populations, specialty hospitals and highly skilled English-speaking medical professionals. Based on his experience in India, Dr. Kabra will provide attendees with insight into the regional challenges and opportunities and he will make recommendations for strategies to overcome the challenges in order to maximize the India advantage.
Dr. Kabra has more than 12 years of experience in the clinical research industry, working in academic institutes, pharmaceutical companies and clinical research organizations. In India, he has monitored more than 100 clinical studies in diverse therapeutic areas. Through his substantial experience, he has developed a comprehensive understanding of the regulatory and ethics processes and has built relationships with key investigative sites in the region.
PRA's presence in India enables its clients to access the compelling opportunities for swift, meticulous, and cost-effective patient recruitment in this region. Through its office in Mumbai, PRA has managed more than 40 clinical trials in India in the last three years.
About PRA International
PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in oncology, neurosciences, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials through its 36 global offices.
PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
SOURCE: PRA International
CONTACT: Roger Boutin, Director of Marketing of PRA International, Inc.,+1-434-951-3924